Dr. Reddy's Laboratories, Incorporated

Anuja Chandrasekar

Murali Jayaraman

The present invention discloses a stable pharmaceutical formulation of an antibody, wherein the formulation contains buffer, surfactant and sugar, and wherein the formulation is devoid of free amino acids and salts.

Stable formulations of therapeutic antibody

The present invention discloses a stable pharmaceutical formulation of an antibody, wherein the formulation contains buffer, surfactant, sugar, and optionally contains a free amino acid. The disclosed formulation is stable at 50° C. for two weeks. In addition, the formulation maintains at least 96% of the antibody in monomeric form under above said storage conditions.

Antibody formulation

The present invention discloses a stable pharmaceutical formulation of an antibody, wherein the formulation contains buffer, surfactant and salt, and wherein the formulation is devoid of free amino acids. The disclosed antibody formulations are liquid formulations that are also suitable for lyophilization.

Growing community of inventors

Chennai, India

Anuja Chandrasekar